{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34237771",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "02",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "07",
        "Day": "08"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41586-021-03792-w"
    ],
    "Journal": {
      "ISSN": "1476-4687",
      "JournalIssue": {
        "Volume": "596",
        "Issue": "7873",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "Nature",
      "ISOAbbreviation": "Nature"
    },
    "ArticleTitle": "After the pandemic: perspectives on the future trajectory of COVID-19.",
    "Pagination": {
      "StartPage": "495",
      "EndPage": "504",
      "MedlinePgn": "495-504"
    },
    "Abstract": {
      "AbstractText": [
        "There is a realistic expectation that the global effort in vaccination will bring the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) under control. Nonetheless, uncertainties remain about the type of long-term association that the virus will establish with the human population and, in particular, whether coronavirus disease 2019 (COVID-19) will become an endemic disease. Although the trajectory is difficult to predict, the conditions, concepts and variables that influence this transition can be anticipated. Persistence of SARS-CoV-2 as an endemic virus, perhaps with seasonal epidemic peaks, may be fuelled by pockets of susceptible individuals and waning immunity after infection or vaccination, changes in the virus through antigenic drift that diminish protection and re-entries from zoonotic reservoirs. Here we review relevant observations from previous epidemics and discuss the potential evolution of SARS-CoV-2 as it adapts during persistent transmission in the presence of a level of population immunity. Lack of effective surveillance or adequate response could enable the emergence of new epidemic or pandemic patterns from an endemic infection of SARS-CoV-2. There are key pieces of data that are urgently needed in order to make good decisions; we outline these and propose a way forward."
      ],
      "CopyrightInformation": "\u00a9 2021. Springer Nature Limited."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-6290-7677"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vir Biotechnology, San Francisco, CA, USA. atelenti@vir.bio."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA. atelenti@vir.bio."
          }
        ],
        "LastName": "Telenti",
        "ForeName": "Amalio",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0001-5404-1498"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vir Biotechnology, San Francisco, CA, USA. aarvin@vir.bio."
          }
        ],
        "LastName": "Arvin",
        "ForeName": "Ann",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0002-2179-2436"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. lcorey@fredhutch.org."
          }
        ],
        "LastName": "Corey",
        "ForeName": "Lawrence",
        "Initials": "L"
      },
      {
        "Identifier": [
          "0000-0002-5797-1364"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio."
          }
        ],
        "LastName": "Corti",
        "ForeName": "Davide",
        "Initials": "D"
      },
      {
        "Identifier": [
          "0000-0002-8791-3165"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA. mdiamond@wustl.edu."
          }
        ],
        "LastName": "Diamond",
        "ForeName": "Michael S",
        "Initials": "MS"
      },
      {
        "Identifier": [
          "0000-0002-6551-1827"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. adolfo.garcia-sastre@mssm.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA. adolfo.garcia-sastre@mssm.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. adolfo.garcia-sastre@mssm.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. adolfo.garcia-sastre@mssm.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. adolfo.garcia-sastre@mssm.edu."
          }
        ],
        "LastName": "Garc\u00eda-Sastre",
        "ForeName": "Adolfo",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, Tulane University, New Orleans, LA, USA. rfgarry@tulane.edu."
          }
        ],
        "LastName": "Garry",
        "ForeName": "Robert F",
        "Initials": "RF"
      },
      {
        "Identifier": [
          "0000-0001-9596-3552"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia. edward.holmes@sydney.edu.au."
          }
        ],
        "LastName": "Holmes",
        "ForeName": "Edward C",
        "Initials": "EC"
      },
      {
        "Identifier": [
          "0000-0002-8811-9801"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vir Biotechnology, San Francisco, CA, USA. ppang@vir.bio."
          }
        ],
        "LastName": "Pang",
        "ForeName": "Phillip S",
        "Initials": "PS"
      },
      {
        "Identifier": [
          "0000-0001-8580-7628"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Vir Biotechnology, San Francisco, CA, USA. svirgin@vir.bio."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. svirgin@vir.bio."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA. svirgin@vir.bio."
          }
        ],
        "LastName": "Virgin",
        "ForeName": "Herbert W",
        "Initials": "HW"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nature",
    "NlmUniqueID": "0410462",
    "ISSNLinking": "0028-0836"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology",
        "supply & distribution"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Evolution, Molecular"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immune Evasion"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunization Programs"
    },
    {
      "QualifierName": [
        "immunology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Influenza, Human"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ]
}